May 20, 2009
AstraZeneca Pharmaceuticals LP has been granted a preliminary injunction in its suit to prevent Apotex Inc. from launching a generic version of children's asthma treatment Pulmicort Respules, a month after a judge issued a temporary restraining order against Apotex.
April 16, 2009
A federal court has temporarily blocked Apotex Inc. from launching a generic version of Pulmicort Respules, AstraZeneca Pharmaceuticals LP’s successful asthma treatment for children.